Abdulrahman Alzmmam

Dr. Abdulrahman Alzmmam


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2026 in Critical Care
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Alzmmam
Abdulrahman Alzmmam
RAReema Fahad Alghanem
Reema Fahad Alghanem
AAAsma Alshahrani
Asma Alshahrani
RARaneem Aljawaied
Raneem Aljawaied
FAFaisal Sulaiman Alolayqi
Faisal Sulaiman Alolayqi
AAAlawi S. Alsaeedi
Alawi S. Alsaeedi
Optimal pain and sedation management in intensive care unit (ICU) remains challenging. While opioids and benzodiazepines are widely used, their adverse eff

2 April 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
MAMansuor A. Alanazi
Mansuor A. Alanazi
SASaeed Ali Alshahrani
Saeed Ali Alshahrani
AEAli Elkarouri
Ali Elkarouri
SASaleh Ahmed Alkholaifi
Saleh Ahmed Alkholaifi
AAAbdulrahman Alzmmam
Abdulrahman Alzmmam
MTMahir Tesfaye
Mahir Tesfaye
Diabetes Mellitus (DM) and liver disease, particularly All Liver Diseases (All-LD), are increasingly interlinked public health concerns in the United State

9 March 2026 in International Journal of Obstetric Anesthesia
Verified
Journal Article
Open access
MAMohammed Aljahdali
Mohammed Aljahdali
OMOmar Al Misnid
Omar Al Misnid
RAReem Altamimi
Reem Altamimi
AAAbdullah Alsharabi
Abdullah Alsharabi
DADanah AlNajjar
Danah AlNajjar
SASulaman Almesned
Sulaman Almesned
Although labor analgesia is a standard component of maternity care, awareness and use remain variable. In Saudi Arabia, high antenatal attendance provides an opportunity for counseling, yet information gaps may still limit informed decision-making. This study assessed awareness of labor analgesia among pregnant women in Riyadh and examined attitudes, previous use, and willingness to use labor analgesia. A cross-sectional study was conducted among 431 pregnant women attending antenatal care at King Abdulaziz Medical City, Riyadh, Saudi Arabia. Data were collected using a structured questionnaire covering sociodemographic characteristics, obstetric history, awareness of labor analgesia, prior experience, attitudes, and willingness to use analgesia. Of the 431 participants, 320 (74.2%) were older than 31 years and 225 (52.2%) held a bachelor's degree. Awareness of labor analgesia was reported by 234 (54.3%), while 197 (45.7%) had no prior information. Epidural analgesia was the most recognized method, reported by 136 (31.6%). Among multiparous women, 209 of 344 (60.8%) had previously used some method to relieve labor pain, and epidural analgesia was the most frequently used option, reported by 75 of 344 (21.8%). Overall, 366 of 431 (84.9%) believed labor pain should be treated. Awareness was higher among older multiparous women, while willingness to use labor analgesia was generally high across subgroups. Awareness of labor analgesia was moderate, but attitudes were favorable and willingness to use analgesia was high. These findings support strengthening structured antenatal counseling, particularly for younger and women with no prior obstetric experience, to improve informed decision-making about labor pain relief.

16 October 2026 in Medicine
Verified
Journal Article
Open access
IAIbraheem Altamimi
Ibraheem Altamimi
ZAZainab Yunus Alfallatah
Zainab Yunus Alfallatah
AAAbdulrahman Alzmmam
Abdulrahman Alzmmam
MAMesfer Alsaqoor
Mesfer Alsaqoor
MAMohammed Ibrahim A. Almakrami
Mohammed Ibrahim A. Almakrami
SASaad Hamdi Alenzi
Saad Hamdi Alenzi
Nasopharyngeal carcinoma (NPC) is a rare but geographically concentrated malignancy. Long-term comparative analyses of NPC trends between the United States and global populations, particularly by sex, are limited. Using Global Burden of Disease 2023 data, we analyzed temporal trends in NPC incidence, prevalence, and mortality from 1990 to 2023 in the United States and worldwide. Age-standardized rates per 100,000 population were calculated. Joinpoint regression estimated annual percent changes (APCs) and average annual percent change (AAPC) with 95% confidence intervals. Pairwise comparisons assessed differences between United States and global trends. Mortality forecasts through 2050 were generated using the established Global Burden of Disease forecasting framework. From 1990 to 2023, US age-standardized mortality declined by 44%, from 0.34 to 0.19 per 100,000 (AAPC: –1.70), while global mortality decreased from 1.46 to 0.83 (AAPC: –1.70). Global mortality increased between 2020 and 2023 (APC: 2.06), unlike the US decline. The incidence rate declined in the United States over the study period (AAPC: –1.03), while remaining largely stable globally. However, global incidence increased between 2020 and 2023 (APC: 3.86). Similarly, prevalence decreased in the United States (AAPC: –0.81) while showing a rising trend worldwide (AAPC: 0.74). Males consistently exhibited higher rates across all measures. Pairwise comparisons showed significant differences between United States and global trends. From 2023 to 2050, global NPC age-standardized mortality rate is projected to increase by 12.05% (0.93, 95% uncertainty interval [UI]: 0.75–1.16), driven by a 21.8% rise in males (1.45, 95% UI: 1.18–1.78), while declining by 11.76% in females (0.45, 95% UI: 0.33–0.63). In the United States, age-standardized mortality rate is projected to increase by 10.5% (0.21, 95% UI: 0.18–0.23), with a 17.9% rise in males (0.33, 95% UI: 0.29–0.37) and an 11.82% decline in females (0.097, 95% UI: 0.08–0.12). US NPC burden has declined steadily, while global patterns show rising prevalence and recent mortality increases. The observed differences in burden and temporal trends underscore the importance of further research into strategies for surveillance, early detection, and prevention in high-risk populations.